Seven-year follow-up of the efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with relapsing-remitting multiple sclerosis: Integrated analysis of DEFINE, CONFIRM, and ENDORSE

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2016
This article has no abstract
Epistemonikos ID: caab893a87d3e54da7dfef42227d2b94b9fe380a
First added on: Apr 29, 2026